Fetoplacental Doppler in gestational hypertension and mild preeclampsia
Doppler fetoplacentario en hipertensión gestacional y preeclampsia leve
Show authors biography
Introduction: preeclampsia occurs in 6% of pregnancies in Colombia and is associated with a high rate of maternal-fetal morbidity and mortality. Often severe cases are accompanied by intrauterine growth restriction; in these cases the fetoplacental doppler is useful to determine the fetal prognosis, but its value in mild preeclampsia or gestational hypertension is not well defined. Objectives: to determine in these two circumstances the frequency of alterations in the Doppler of the umbilical and middle cerebral arteries. Materials and methods: search of cases in the database of the maternal-fetal medicine unit of the Hospital of San José, between August 2006 and February 2008. Patients with gestations> at 28 weeks with HTG or PL and fetuses were defined as cases. with normal growth profile. We considered and analyzed demographic variables, fetoplacental Doppler results and complications. Results: 85 patients were identified. 17% presented UA Doppler alteration and 7% of the ACM; in gestations <32 weeks the abnormal findings are low (75% AU and 85% normal MCA). Conclusions: the frequency of alterations in UA and ACM Doppler was similar in the group of women who presented complications and those with a normal outcome. Abbreviations: IUGR, intrauterine growth restriction; PL, mild preclampsia; HTG, gestational hypertension; AU, umbilical artery; ACM, middle cerebral artery.
Article visits 318 | PDF visits 1951
Downloads
1. López-Jaramillo P. Bioquímica del endotelio vascular: implicaciones fisiológicas y clínicas. 5a ed. Bogotá: Horizonte impresores; 2001.
2. Norwitz ER. Implantation and the survival of early pregnancy. N Eng J Med. 2001;59(6):1400-18.
3. Spectral Doppler sonography, wave form analysis and hemodynamic interpretation. In: Maulik D, editor. Doppler ultrasound in obstetrics and gynecology. New York: Springer Verlag; 1997. p. 55.
4. Pridjian G, Puschett JB. Clinical and pathophysiologic considerations of preeclampsia. Obs Gynecol Surv. 2002; 57(9):598-618.
5. Walker JJ. Preeclampsia. Lancet. 2000 ;356(9237):1260-5.
6. Pridjian G, Puschett JB. Preeclampsia part 2: experimental and genetic considerations. Obstet Gynecol Surv. 2002; 57(9): 619-40.
7. Wilson ML, Goodwin TM, Pan VL, Ingles SA. Molecular epidemiology of preeclampsia. Obst Gynecol Surv. 2002; 58(1):1158-68.
8. Page NM. The endocrinology of pre-eclampsia. Clin Endocrinol (Oxf). 2002; 57(4):413-23.
9. Gillham JC. An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. Eur J Obst Gynecol Rep Biol. 2003;109:2-7.
10. Arslan M. Endothelin-1 and leptin in the pathophysiology of intrauterine growth restriction. Int J Gynaecol Obstet. 2004; 84(2):120-6.
11. Balat O, Aksoy F, Kutlar I, Ugur MG, Iyikosker H, Balat A, et al. Increased plasma levels of urotensin-II in preeclampsiaeclampsia: a new mediator in pathogenesis?. Eur J Obstet Gynecol Reprod Biol. 2005; 120(1):33-8.
12. López-Jaramillo P, Terán E, de Félix M, Villacres M, Barba L, Moya W. Papel del óxido nítrico durante el embarazo normal y la preeclampsia. Rev Colomb Cardiol. 1998; 6:169-76.
13. Chervenak F, Kurjak A. The clinical care of the fetus as a patient. In: Kurjak A, Chervenak F, editors. The fetus as a patient. London: The Parthenon Publishing Group, 1994.
14. Merivel P. Physiopatology of pre-eclampsia and intrauterine growth restriction. In: Kurjak A, Chervenak F, editors. The fetus as a patient. London: The Parthenon Publishing Group, 1994. 347-55.
15. Dash PR, Cartwright JE, Baker PN, Johnstone AP, Whitley GS. Nitric oxide protects human extravillous trophoblast cells from apoptosis B a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation. Exp Cell Res. 2003; 287(2):314-24.
16. Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev. 2010 Jan; (1): CD000073.
17. Papagergeorghiou AT. Predicting and preventing preeclampsia where to next?. Ultrasound Obstet Gynecol. 2008;31(4): 370- 6.
18. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003; 189(4):1173-7.
19. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypotesis and its implications. Am J Obstet Gynecol. 1996; 175:1365-70.
20. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities?. Clin Sci. (London) 2004; 106: 377-82.
21. Bricker L, Neilson JP, Dowswell T.. Routine ultrasound in late pregnancy (after 24 weeks gestation). Cochrane Database Syst Rev. 2008 Oct 8;(4):CD001451
22. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG. 2004; 111(4):298-302.
23. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22(2):143-8.
Information
Keywords
